Phathom Pharmaceuticals (PHAT) Cash from Operations (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has 9 years of Cash from Operations data on file, last reported at 15647000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 81.58% year-over-year to 15647000.0 in Q1 2026; TTM through Mar 2026 was 97492000.0, a 65.51% increase from a year earlier, with the FY2025 full-year figure at 166775000.0, up 37.48% from the prior year.
• Cash from Operations for Q1 2026 stood at 15647000.0, down from 5001000.0 in the prior quarter.
• Over the last five years, Cash from Operations for PHAT reached as high as 5001000.0 in Q4 2025 and fell as low as 84930000.0 in Q1 2025.
• Historically, Cash from Operations has averaged 43135411.76 across 5 years, with a median of 41041000.0 in 2022.
• Across the five-year window, Cash from Operations slumped 218.56% in 2024 and soared 92.12% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 41041000.0 in 2022, then decreased by 6.72% to 43797000.0 in 2023, then sank by 44.89% to 63456000.0 in 2024, then surged by 92.12% to 5001000.0 in 2025, then sank by 212.88% to 15647000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 15647000.0 in Q1 2026, 5001000.0 in Q4 2025, and 14115000.0 in Q3 2025.